Skip to main content

Press Releases

September 10, 2020

SCHAUMBURG, IL – Today, following the deadline for e-cigarette manufacturers to submit Premarket Tobacco Product Applications (PMTA) to the FDA in order to legally continue selling their devices in the United States, Congressman Raja Krishnamoorthi announced he will introduce legislation to add transparency and review to the e-cigarette approval process. The Independent Advisory Committee Review of E-Cigarette Applications Act will:

•Require the FDA to publicly list all PMTAs it receives from e-cigarette manufacturers.


September 9, 2020

SCHAUMBURG, IL – Following the Chicago City Council's overwhelming vote in favor of banning flavored e-cigarette sales within city limits, Congressman Raja Krishnamoorthi applauded local leaders for their decisive action to protect youth public health.


September 3, 2020

SCHAUMBURG, IL – Today, Congressman Raja Krishnamoorthi (IL) and Congresswoman Val Demings (FL) wrote to the Director of National Intelligence (DNI), John Ratcliffe, calling for the DNI make available to the public information regarding any actions taken by foreign adversaries to exploit tensions and social unrest in American communities with intent to influence the upcoming election. This follows a previous request by Members of the House Permanent Select Committee on Intelligence to which the DNI responded with a classified letter, which cannot be made public.


August 28, 2020

SCHAUMBURG, IL – Today, Congressman Raja Krishnamoorthi continued his investigation into serious ethical questions surrounding Marc Short, Vice President Pence's Chief of Staff and principal aide to the Coronavirus Task Force, by writing to the Office of the Vice President (OVP) with regard to its handling of Mr. Short's conflicts of interest and to the Office of Government Ethics (OGE) on its oversight of the OVP's ethics program.


August 27, 2020

WASHINGTON, DC – On Wednesday, Congressmen Raja Krishnamoorthi (IL-08) and Don Beyer (VA-08) wrote to Special Counsel Henry Kerner, calling upon the Office of Special Counsel (OSC) to investigate the apparent Hatch Act violations committed by members of the Trump Administration during the RNC, most notably the pardon and citizenship ceremony included in the nationally-televised event.


August 25, 2020

SCHAUMBURG, IL – Today, Congressman Raja Krishnamoorthi wrote to the Office Of Government Ethics (OGE) regarding the potential failures of the USPS Ethics Office to fully address Postmaster General Louis DeJoy's potential conflicts of interest based on his substantial investment portfolio because, as OGE has publicly stated, under 18 U.S.C.


August 20, 2020

SCHAUMBURG, IL – Today, Congressman Raja Krishnamoorthi (IL-08) and Congresswoman Katie Porter (CA-45) wrote to John Barger of the US Postal Service Board of Governors requesting information regarding the selection of Louis DeJoy for the position of Postmaster General.


August 11, 2020

SCHAUMBURG, IL – In response to a new study on adolescent vaping, led by Dr. Bonnie Halpern-Felsher of Stanford University and published today in the Journal of Adolescent Health, finding that e-cigarette users are five times more likely to be diagnosed with COVID-19 than non-vapers, Chairman Raja Krishnamoorthi of the Oversight Subcommittee on Economic and Consumer Policy wrote to Food and Drug Administration (FDA) Commissioner Dr. Stephen M.


August 10, 2020

SCHAUMBURG, IL – Congressman Raja Krishnamoorthi issued the statement below in response to an article in the Journal of the American Medical Association authored by FDA's leadership stating specifically, "Given the widespread potential use of a COVID-19 vaccin


August 6, 2020

WASHINGTON, DC – Today, Rep. Raja Krishnamoorthi (D-IL), Chairman of the House Oversight Subcommittee on Economic and Consumer Policy, introduced the "Expeditious Vaccine Advice with Legitimate, Unbiased, Apolitical, and Technical Expertise Act," or the "EVALUATE Act," to require the Food and Drug Administration (FDA) to solicit and consider advice from the Vaccines and Related Biological Products Advisory Committee (VRBPAC) before licensing or authorizing any COVID-19 vaccine. Rep.